The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Davis, J. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Davis, J. M.

Am J Psychiatry 1975; 132:1237-1245
Copyright © 1975 by American Psychiatric Association


SPECIAL ARTICLES

Overview: maintenance therapy in psychiatry: I. Schizophrenia

JM Davis

Hospital psychiatry has evolved from long-term "treatment" programs that were primarily custodial to the successful pharmacological treatment of acute psychotic episodes. Unfortunately, many patients still return to the hospital with relapses. This so-called revolving door syndrome draws attention to the critical importance of preventing as well as treating acute episodes. In the first part of this overview, the author reviews the clinical literature on prophylactic treatment of schizophrenia with maintenance antipsychotic drugs. The second part will review the literature on prophylactic treatment of affective disorders with lithium and tricyclics. In the opinion of the author these drugs provide the potential for truly preventive psychiatry.


This article has been cited by other articles:


Home page
Schizophr BullHome page
C. E. Adams, E. S. F. Coutinho, J. Davis, L. Duggan, S. Leucht, C. Li, and P. Tharyan
Cochrane Schizophrenia Group
Schizophr Bull, March 1, 2008; 34(2): 259 - 265.
[Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. A. Lieberman
Comparative Effectiveness of Antipsychotic Drugs: A Commentary on Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).
Arch Gen Psychiatry, October 1, 2006; 63(10): 1069 - 1072.
[Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
A. M. Mortimer
Another triumph of hope over experience?: REVISITING... TREATMENT OF THE PATIENT WITH LONG-TERM SCHIZOPHRENIA
Advan. Psychiatr. Treat., July 1, 2005; 11(4): 277 - 285.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
M. J Ehret and M. A Fuller
Long-Acting Injectable Risperidone
Ann. Pharmacother., December 1, 2004; 38(12): 2122 - 2127.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
N. R. Schooler
Maintenance Medication for Schizophrenia: Strategies for Dose Reduction
Focus, January 1, 2004; 2(1): 175 - 186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. M. Kane, J. M. Davis, N. Schooler, S. Marder, D. Casey, B. Brauzer, J. Mintz, and R. Conley
A Multidose Study of Haloperidol Decanoate in the Maintenance Treatment of Schizophrenia
Am J Psychiatry, April 1, 2002; 159(4): 554 - 560.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
I. Kleinman and D. Schachter
Obtaining Informed Consent of Patients at Risk of Neuroleptic Malignant Syndrome
Psychiatr Serv, September 1, 2000; 51(9): 1182 - 1183.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. I. Herz, J. S. Lamberti, J. Mintz, R. Scott, S. P. O'Dell, L. McCartan, and G. Nix
A Program for Relapse Prevention in Schizophrenia: A Controlled Study
Arch Gen Psychiatry, March 1, 2000; 57(3): 277 - 283.
[Abstract] [Full Text] [PDF]


Home page
International Journal of Social PsychiatryHome page
K. Bhui
The Language of Compliance: Health Policy and Clinical Practice for the Severely Mentallyill
International Journal of Social Psychiatry, September 1, 1997; 43(3): 157 - 163.
[Abstract] [PDF]


Home page
J Am Psychiatr Nurses AssocHome page
K. H. Littrell
Beyond Compliance: Evaluating Antipsychotic Efficacy
Journal of the American Psychiatric Nurses Association, October 1, 1996; 2(5): 186 - 190.
[Abstract] [PDF]


Home page
NEJMHome page
J. M. Kane
Schizophrenia
N. Engl. J. Med., January 4, 1996; 334(1): 34 - 42.
[Full Text] [PDF]


Home page
International Journal of Social PsychiatryHome page
B.-Y. Rhi, K.-S. Ha, Y.-S. Kim, Y. Sasaki, D. Young, T.-H. Woon, L. T.R. Laraya, and Y. Yanchun
The Health Care Seeking Behavior of Schizophrenic Patients in 6 East Asian Areas
International Journal of Social Psychiatry, September 1, 1995; 41(3): 190 - 209.
[Abstract] [PDF]


Home page
NEJMHome page
W. T. Carpenter and R. W. Buchanan
Schizophrenia
N. Engl. J. Med., March 10, 1994; 330(10): 681 - 690.
[Full Text]


Home page
J PsychopharmacolHome page
E. C. Johnstone, T.J. Crow, D.G.C. Owens, and C.D. Frith
The Northwick Park 'Functional' Psychosis Study. Phase 2: maintenance treatment
J Psychopharmacol, January 1, 1991; 5(4): 388 - 395.
[Abstract] [PDF]


Home page
Cross-Cultural ResearchHome page
D. Baskin
A Cross-National Survey of Mental Illness and Treatment
Cross-Cultural Research, January 1, 1982; 17(3-4): 246 - 270.
[Abstract] [PDF]


Home page
ScienceHome page
P. Berger
Medical treatment of mental illness
Science, May 26, 1978; 200(4344): 974 - 981.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1975 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org